Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram Titration in Early Non-responders with MDD
NCT03899285Phase 2Completed
- Start
- Jan 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of citalopram in major depressive disorder (MDD). Started Jan 2018; status: completed.
02
Drugs
citalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03899285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03899285.